Future Care for Medical Industries (FCMI) results, Q1 2024
Net profit, assets, equity and cash flow for Q1 2024, against the same period a year earlier, from the published financial statements.
Net profit483 thousandEGP · +281.0% vs the same period a year earlier
Total assets105 millionEGP · +74.2% vs the same period a year earlier
Shareholders' equity61.7 millionEGP · +6.5% vs the same period a year earlier
Operating cash flow-155 thousandEGP · −115.4% vs the same period a year earlier
In short
- Future Care for Medical Industries (FCMI)'s net profit for Q1 2024 was about 483 thousand EGP, up +281.0% from 127 thousand EGP in Q1 2023.
- Total assets at the end of Q1 2024 were about 105 million EGP, and shareholders' equity about 61.7 million EGP.
- Operating cash flow for Q1 2024 was negative at 155 thousand EGP.
Key lines against the same period a year earlier
This periodQ1 2023Change
Net profit483 thousand127 thousand+281.0%
Gross profit2.22 million1.56 million+42.5%
Total assets105 million60.49 million+74.2%
Total liabilities43.71 million2.54 million+1620.4%
Shareholders' equity61.7 million57.95 million+6.5%
Total liabilities and equity105 million60.49 million+74.2%
Operating cash flow-155 thousand1.01 million−115.4%
Investing cash flow———
Financing cash flow-547 thousand-9.86 million+94.5%
Net change in cash-702 thousand-8.85 million+92.1%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Future Care for Medical Industries (FCMI)'s Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy